Large-cell anaplastic lymphoma-specific translocation in Hodgkin's disease.

W. C. Chan; G. Elmberger; M. D. Lozano; W. Sanger; D. D. Weisenburger

Large-cell anaplastic lymphoma-specific translocation in Hodgkin's disease.

W. C. Chan, G. Elmberger, M. D. Lozano, W. Sanger, D. D. Weisenburger

Research output: Contribution to journal › Comment/debate › peer-review

Original language	English (US)
Pages (from-to)	921
Number of pages	1
Journal	Lancet
Volume	345
Issue number	8954
State	Published - Apr 8 1995
Externally published	Yes

ASJC Scopus subject areas

Medicine(all)

Cite this

@article{8467b2c728f44b85b66f378ab7591b97,

title = "Large-cell anaplastic lymphoma-specific translocation in Hodgkin's disease.",

author = "Chan, {W. C.} and G. Elmberger and Lozano, {M. D.} and W. Sanger and Weisenburger, {D. D.}",

note = "Funding Information: efficient amplification of the NPM/ALK fusion message. Another possibility is that there are fundamental differences between the patient populations. Either the diagnostic criteria for Hodgkin{\textquoteright}s disease differ between the studies or there is a fundamental difference between Hodgkin{\textquoteright}s disease in Europe and North America. Whatever the ultimate reasons for the differences, results suggest that t(2;5) is rarely if ever detected in cases of Hodgkin{\textquoteright}s disease, and, furthermore, support the notion that Hodgkin{\textquoteright}s disease and t(2;5)-containing large-cell lymphoma distinct clinicopathological entities. This work was supported in part by NIH grants CA-01429 (JRD)j CA-50341 (LMW), Cancer Center Core Grant CA-21765, American Cancer Society Clinical Oncology Career Development Award 93-38 (ML), and by the American Lebanese Syrian Associated Charities of St Jude Children{\textquoteright}s Research Hospital.",

year = "1995",

month = apr,

day = "8",

language = "English (US)",

volume = "345",

pages = "921",

journal = "The Lancet",

issn = "0140-6736",

publisher = "Elsevier Limited",

number = "8954",

}

TY - JOUR

T1 - Large-cell anaplastic lymphoma-specific translocation in Hodgkin's disease.

AU - Chan, W. C.

AU - Elmberger, G.

AU - Lozano, M. D.

AU - Sanger, W.

AU - Weisenburger, D. D.

N1 - Funding Information: efficient amplification of the NPM/ALK fusion message. Another possibility is that there are fundamental differences between the patient populations. Either the diagnostic criteria for Hodgkin’s disease differ between the studies or there is a fundamental difference between Hodgkin’s disease in Europe and North America. Whatever the ultimate reasons for the differences, results suggest that t(2;5) is rarely if ever detected in cases of Hodgkin’s disease, and, furthermore, support the notion that Hodgkin’s disease and t(2;5)-containing large-cell lymphoma distinct clinicopathological entities. This work was supported in part by NIH grants CA-01429 (JRD)j CA-50341 (LMW), Cancer Center Core Grant CA-21765, American Cancer Society Clinical Oncology Career Development Award 93-38 (ML), and by the American Lebanese Syrian Associated Charities of St Jude Children’s Research Hospital.

PY - 1995/4/8

Y1 - 1995/4/8

UR - http://www.scopus.com/inward/record.url?scp=0029639241&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029639241&partnerID=8YFLogxK

M3 - Comment/debate

C2 - 7766245

AN - SCOPUS:0029639241

VL - 345

SP - 921

JO - The Lancet

JF - The Lancet

SN - 0140-6736

IS - 8954

ER -

Large-cell anaplastic lymphoma-specific translocation in Hodgkin's disease.

ASJC Scopus subject areas

Other files and links

Cite this